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Abstract: In this study, procyanidin dimers and Leucosidea sericea total extract (LSTE) were employed
in the synthesis of silver nanoparticles (AgNPs) and characterized by ultraviolet-visible (UV-Visible)
spectroscopy, high-resolution transmission electron microscopy (HRTEM), selected area electron
diffraction (SAED), X-ray diffraction (XRD), and dynamic light scattering (DLS) techniques. AgNPs of
about 2–7 nm were obtained. DLS and stability evaluations confirmed that the AgNPs/procyanidins
conjugates were stable. The formed nanoparticles exhibited good inhibitory activities against the
two enzymes studied. The IC50 values against the amylase enzyme were 14.92 ± 1.0, 13.24 ± 0.2,
and 19.13 ± 0.8 µg/mL for AgNPs coordinated with LSTE, F1, and F2, respectively. The corresponding
values for the glucosidase enzyme were 21.48 ± 0.9, 18.76 ± 1.0, and 8.75 ± 0.7 µg/mL. The antioxidant
activities were comparable to those of the intact fractions. The AgNPs also demonstrated bacterial
inhibitory activities against six bacterial species. While the minimum inhibitory concentrations (MIC)
of F1-AgNPs against Pseudomonas aeruginosa and Staphylococcus aureus were 31.25 and 15.63 µg/mL
respectively, those of LSTE-AgNPs and F2-AgNPs against these organisms were both 62.50 µg/mL.
The F1-AgNPs demonstrated a better bactericidal effect and may be useful in food packaging.
This research also showed the involvement of the procyanidins as reducing and capping agents in the
formation of stable AgNPs with potential biological applications.
Keywords: biosynthesis; procyanidins dimers; Leucosidea sericea; silver nanoparticles; phytoconstituents;
antimicrobial; antidiabetic; antioxidant
1. Introduction
Metallic nanoparticles are of great interest owing to their unique physicochemical characteristics as
well as their potential biomedical applications [1]. The characteristic properties of metallic nanoparticles
(MNPs) such as silver nanoparticles (AgNPs) depend on the methods of preparation and the nature of
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the precursors [1]. Physical methods [2,3] have been used to prepare AgNPs; however, they are not
cost-effective, consume more energy, and involve the use of sophisticated instruments [4]. Through
the chemical procedures, reducing agents such as hydrazine have been employed in the formation of
MNPs [1]. Although the nanoparticles possess interesting characteristic features, they have limited
biological applications due to toxicity concerns [5]. Their stability is usually enhanced with the use of
external stabilizers, some of which are also toxic [6]. Using biological resources to synthesize AgNPs,
among which plants are more popular [7–9], could eliminate the toxicity problem. Plants are readily
accessible, non-toxic, and can be easily handled [10]. Plants also possess phytochemicals, serving not
only as reducing, but also as capping agents, making the synthesis a facile process [11].
Several AgNPs have been successfully biosynthesized using various plant extracts such as
Nigella arvensis L [12], Pelargonium graveolens [13], Theobroma cacao and Vitis vinifera seed [14], Putranjiva
roxburghii [15], Combretum erythrophyllum [16], and Ducrosia anethifolia [17]. An array of spectroscopic and
microscopic techniques have been employed to characterize the AgNPs [11,13,15,16,18]. In these extracts,
phytoconstituents such as polyphenols are believed to be responsible for the reduction and stabilization
of the AgNPs. To identify them, Fourier-transform infrared (FTIR) spectroscopy was employed [19]
in addition to nuclear magnetic resonance (NMR) spectroscopy [20] and high-performance liquid
chromatography coupled with mass detector (LC-MS) [21]. Fractions or pure natural compounds
have also been used in the green synthesis of nanoparticles [22] and examples include tannic acid [23],
quercetin, gallic acid [24], and other compounds [25,26]. Green synthesis is the preferred procedure
for the formation of biocompatible nanoparticles [27]. However, better knowledge of the chemical
composition of the extracts or fractions is necessary to further understand the role of the phytochemicals
either as the reducing or capping agent or both. Moreover, little is known about procyanidins in
higher plants and their reducing/capping abilities in green synthesis. This was one of the aims of the
present study.
Furthermore, biosynthesized AgNPs prepared from the chemical constituents of various
plant extracts and compounds have shown potent antioxidant [28,29], antidiabetic [30–33] and
antibacterial [34] activities. However, further studies are necessary on these greener alternatives.
Leucosidea sericea Eckl and Zeyh is an evergreen shrub that belongs to the family Rosaceae. Nine out
of its 3000 species are found in South Africa and its neighboring countries. Commonly called “old wood,”
the plant grows on both dry and wetlands. It has a silvery, woody bark and can be up to 7 m in
height [35]. The extract from this plant has been used to cure many ailments and has proven biological
properties [36,37]. A number of compounds have been isolated from the extract of L. sericea and
showed various bio-activities [35,38,39]. The mentioned traits awaken the curiosity to further investigate
this wonder plant. Recently, our group identified procyanidins in the extract for the first time [40].
Procyanidins are a higher class of polyphenols with unique chemical structure, and mostly occur in fruits
and vegetables. Their presence is, therefore, a pointer to the significance of this plant. The quality of raw
materials used as food depends largely on phenolic compounds such as procyanidins [41]. Because of
the abundant presence in fruits, legumes, cereals, and a variety of beverages, procyanidins represent
up to 50% of dietary polyphenols we consume daily [42]. These procyanidins have displayed diverse
biological activities, and their polyphenolic nature may offer them enhanced biochemical activities [43,44].
Recent studies reported an increase of bioavailability for the flavonoid epigallocatechin gallate when
capped with metal NPs [45], and this may be applicable to procyanidins as well. As mentioned,
the unique chemical structures of procyanidins, have also rendered them excellent reducing and
capping agents [40] that have the capability to synthesize stable, safe, and bio-active metal nanoparticles
with possible future medical applications. In the same context and to avoid using toxic ingredients,
the present study employed highly purified procyanidin dimers and fractions for the formation of
stable and bioactive AgNPs. Their potential antioxidant, antidiabetic, and antimicrobial properties were
evaluated and a detailed mechanism on the involvement of procyanidins in the formation of AgNPs
was proposed.
J. Funct. Biomater. 2020, 11, 66 3 of 20
2. Materials and Methods
2.1. Materials
Polystyrene 96-well microtitre plates were supplied by Greiner bio-one GmbH (Frickenhausen,
Baden-Württemberg, Germany). Silver nitrate, iron (III) chloride hexahydrate, 2,4,6-tris(2-pyridyl)-s-
triazine, hydrochloric acid (HCl), alpha-glucosidase (Saccharomyces cerevisiae), alpha-amylase (procaine
pancreas), 3,5-dinitro salicylic acid (DNS), p-nitrophenyl-α-D-glucopyranoside (p-NPG), sodium carbonate
(Na2CO3), sodium dihydrogen phosphate, Ampicillin, disodium hydrogen phosphate, trolox (6-hydroxyl-2,
5, 7, 8-tetramethylchroman-2-carboxylic acid), 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS) diammonium salt, iodonitrotetrazolium chloride (INT), potassium peroxodisulphate, gallic
acid, vitamin C, and sodium chloride (NaCl) were bought from Sigma-Aldrich (Cape Town, Western
Cape, South Africa). N-Acetyl-L-cysteine (CYS), glycine (GLY), and Folin-Ciocalteu’s phenol reagent
(FC) were procured from Boehringer Mannheim GmbH (Mannheim, Baden-Württemberg, Germany).
Phosphate buffered saline (PBS) was purchased from Lonza (Cape Town, Western Cape, South Africa).
Bovine serum albumin (BSA) was procured from Miles Laboratories (Pittsburgh, PA, USA). Brain-heart
infusion broth (BHI) and Mueller-Hinton Agar were purchased from Biolab (Merck, Modderfontein,
South Africa). A microtitre plate reader (BMG Labtech, Ortenberg, Germany) was employed in reading
the absorbance of the AgNPs and in biological studies. A high-resolution transmission electron
microscopy (FEI Tecnai G2 F20 S-Twin HRTEM, operated at 200 kV) was used to study the morphology
of the AgNPs. X-ray diffraction (XRD; Bruker (Billerica, MA, USA) AXS D8 advance diffractometer with
CuKα1 radiation (λ = 1.5406 Å)) was employed to study the crystallinity of the particles. A Malvern
Zetasizer Instrument (Malvern Ltd., Worcestershire, UK) was used for DLS examinations.
2.2. Extraction of Phytochemicals and Formation of SILVER Nanoparticles
2.2.1. Extraction and Purification of Chemical Constituents
The aerial parts of Leucosidea sericea were extracted with 50% aqueous-ethanol to render the
total extract (referred to as LSTE). A portion of the total extract was partitioned in ethyl acetate and
subsequently purified using different chromatographic techniques [40]. Briefly, silica gel column
chromatography was employed using a gradient of hexane and ethyl acetate of increasing polarity.
The fractions containing procyanidins were further chromatographed on silica gel using isocratic ethyl
acetate. The combined fractions from the above were then subjected to smaller column (3 × 30 cm)
chromatography using sephadex using methanol/water (90:10 and/or 80–20). The fraction(s) which
demonstrated a single spot on the TLC were submitted for NMR analysis to further confirm the purity.
These fractions were labelled F1 and F2, and submitted for both NMR and LC-MS analyses. The spectra
revealed the presence of procyanidins in F1 and F2.
2.2.2. Biosynthesis of Silver Nanoparticles
The synthesis of AgNPs was done by dissolving 20 mg of the aerial part extract (LSTE), F1, or F2
in 2 mL of deionized Milli-Q water and vortexing for 5 min. The resulting yellowish solution was
then added to a 70 mL of 1.0 mM silver nitrate solution at 70 ◦C. After 10 min, a colour change was
observed from yellowish to brown, which confirmed the successful synthesis of AgNPs. The reaction
was monitored with absorbance reading (300–650 nm) until no further changes were noticed. The heat
was removed, and the reaction mixture stirred for another 1 h in the dark. The colloidal solutions were
allowed to cool to room temperature before several washing centrifuge steps. This was done to remove
any unreacted substances that may still be in the solution.
2.3. Stability Evaluation of AgNPs
The procedure of Elbagory et al. [46] was adopted with minor adjustments. Briefly, 0.5% (NaCl,
CYS, GLY, and BSA), deionized water, and PBS (pH 7 and 9) were used. The evaluation was carried
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out in a 96-well plate where the colloidal solution and the freshly prepared media and buffers were
added. For every 160 µL of the colloidal solution, a volume of 80 µL of the above solutions was added
in a different well. This was manually agitated for proper mixing and the absorbance immediately
measured. This was termed as the zero-hour reading. The plate was then covered, wrapped in
aluminum foil, and incubated at 37 ◦C for 24 h. After 24 h, another measurement was then taken and
the plate was returned to the oven for an additional 24 h. At the end of this time, the 48 h reading was
taken. This process was followed for each of the three (LSTE, F1, and F2) AgNPs.
2.4. Dilution Study
The sample of AgNPs in the powdered form was obtained as reported by Badeggi and
colleagues [40]. Briefly, 15 mL of the sample was freeze-dried in a falcon tube after several washing
and centrifugation steps. 300 µL of the synthesized AgNPs were measured at different concentrations.
The concentrations were also plotted alongside the intensity to understand the linearity of the readings.
2.5. In-Vitro Enzymatic Assay
2.5.1. Alpha-Amylase Inhibitory Activity
A standard protocol was employed where 50 µL of phosphate buffer (0.01 M, pH 6.9), 20 µL of
procaine pancreatic alpha-amylase (2U/mL) solution, and 20 µL of the samples were all added in a
96-well plate and incubated for 20 min at room temperature [47]. After this pre-incubation, 20 µL
of 1% soluble starch was added to the mixture and incubated for an additional 30 min. This was
immediately followed by the addition of 100 µL of 3,5-dinitro salicylic acid (DNS) which stopped
the reaction. The reaction mixture was then incubated in a boiling water bath for 10 min before the
absorbance was read at 540 nm. Acarbose was used as the standard and each experiment was done in
triplicate. Equation (1) was used to calculate the percentage inhibition of the alpha-amylase activity.







where C and T are absorbance readings of the control and the treated sample, respectively.
2.5.2. Alpha-Glucosidase Inhibitory Activity
A standard procedure of the alpha-glucosidase assay was followed with slight modification [30].
Briefly, 20 µg/mL of the three AgNP samples was serially diluted in a 96-well plate using a 100 mM
phosphate buffer (PBS) at pH 6.8. The mixture was gently agitated and allowed to stand for 15 min
at 25 ◦C. Thereafter, 20 µL of a 5 mM p-nitrophenyl-α-D-glucopyranoside (p-NPG) was added as
the substrate and the plate was incubated at 37 ◦C for 20 min. Hereafter, 50 µL of a 0.1 M Sodium
carbonate (Na2CO3) solution was added to each well to stop the reaction. With the aid of a plate reader,
the absorbance measurement was then taken at 540 nm. The wells with enzyme, buffer, and substrate
but without samples served as positive controls and each experiment was conducted in triplicate.
The percentage inhibition of the enzymatic property of alpha-glucosidase was determined using
Equation (1) in Section 2.5.1.
2.6. Antibacterial Activity
The protocol description of Elbagory et al. [46] was adopted with slight changes. Briefly, BHI was
used for the serial dilution of the three AgNPs to include six concentrations, i.e., 125.00, 62.50, 31.25,
15.63, 7.81, and 3.90 µg/mL. The six bacterial test species Pseudomonas aeruginosa, Staphylococcus aureus,
Bacillus cereus, Salmonella enterica, Escherichia coli and Serratia marcescens (in PBS) were standardized
to 0.5 McFarland equivalents and further diluted in BHI. Three negative controls were included and
consisted of (i) 200 µL BHI, (ii) 200 µL of sterilized deionized water, and (iii) a mixture of 100 µL of
bacterial cells and 100 µL of sterilized deionized water. After 24 h incubation at 37 ◦C, 40 µL of INT
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was added and further incubated for 2 h before visualization for turbidity. All tests were done in
triplicate. Ampicillin was employed as a positive control and the selected bacteria were wild types.
2.7. Antioxidant Activity
2.7.1. Ferric Reducing Antioxidant Power (FRAP) Assay
The FRAP assay was conducted by adding 10 µL of the sample as well as the standard (ascorbic
acid) to a 96-well plate [48]. Thereafter, 300 µL of the FRAP reagent (3 mL of iron (III) chloride
hexahydrate + 3 mL of 2,4,6-tris(2-pyridyl)-s-triazine + 30 mL of acetate buffer + 6 mL of water) was
added to all the wells. The reaction mixture was allowed to stand for 30 min at room temperature
before the absorbance reading was taken at 593 nm. This assay was done in triplicate and the results
were expressed as mM ascorbic acid equivalents per Gram (mM AAE/g).
2.7.2. Folin–Ciocalteu (FC) Assay
The procedure of Salari et al. [49] was adopted with slight changes. Briefly, 25 µL of both the
standard and the samples were added to a 96-well plate. The Folin–Ciocalteu’s phenol reagent (125 µL)
was added followed by 100 µL of Na2CO3 solution. The plate was allowed to stand on the bench for
2 h at room temperature before the absorbance reading was taken at 765 nm. The experiment was
conducted in triplicate and the results expressed mM gallic acid equivalents per Gram (mM GAE/g).
2.7.3. 2,2′-Azino-bis-3-Ethylbenzotiazolin-6-Sulfonic Acid (ABTS) Assay
The method of Pu and co-workers [48] was adopted and slightly modified. In this experiment,
25 µL of the standard (Trolox) and samples were added to a 96-well plate followed by the ABTS reagent.
The reaction mixture was allowed to stand for 30 min before the absorbance was read at 734 nm.
The ABTS reagent was prepared 30 min before the experiment at 70 ◦C. The assay was repeated two
more times. The results were expressed as mM Trolox equivalents per Gram sample (mM TE/g).
2.8. Statistical Analysis
The results of the bioactivities were analysed using two-way ANOVA followed by post hoc Tukey’s
multiple comparisons test using GraphPad Prism software version 6.05 for Windows (GraphPad
Software, La Jolla, CA, USA (www.graphpad.com)). The image analysis software ImageJ 1.50b version
1.8.0_60 (http://imagej.nih.gov/ij) and Origin pro 2019 64 bits were used to analyse the TEM and
XRD images.
3. Results and Discussion
3.1. Identification and Mechanism of Procyanidin-AgNPs Formation
In our previous work, nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-
mass spectrometry (LC-MS) aided the identification of F2, F1 and LSTE [40] contents. F1 showed
a mixture of procyanidin dimers and trimers, while F2 showed a very pure isomeric structure of
procyanidin dimers (type-B). On the other hand, the total extract (LSTE) showed in addition to
procyanidins dimers and trimers, small flavonoids, and phenolic acids. Taking the B-type procyanidin
dimers as an example (fraction F2), the mechanism of formation of AgNPs is demonstrated (Scheme 1).
Following the green synthesis protocols, the starting materials were dissolved in ultrapure water.
As water ionizes into protons and hydroxyl ions, the OH- abstracts a proton from one of the hydroxyl
groups on the compound (e.g., procyanidin B3) and an alkoxide ion is generated. The alkoxide species
then reduces the silver ion (Ag+) to Ag0, thereby generating the NPs, and since the oxidation products
depend on the alkoxide precursor, quinones are formed (Scheme 1) [50].
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Scheme 1. Proposed mechanism of procyanidin-mediated silver nanoparticles formation.
The proposed mechanisms were based on the following: Firstly, several polyphenols have been
employed in Au- and AgNPs formation, the success of which has been ascribed to the presence of
one or more hydroxyl groups [11,20,51,52]. Interestingly, procyanidins are poly-hydroxy compounds,
confirming their suitability. In addition, to date, there has not been any report, as far as we know,
on the successful fabrication of Au- or AgNPs using pure compounds without at least one hydroxyl
functional group. Secondly, we hypothesized that alkoxide ions generated from the compounds are the
chief reducing agents in the biosynthesis of AgNPs. This conclusion was made based upon potassium
tert-butoxide being used as a reducing agent for the formation of Au and AgNPs through the green
method. Upon the addition of tert-butoxide solution to gold and silver solutions, red and yellow
colours appeared respectively [50]. Since the solution contained only K+ and tert-butoxide ion, it is
evident that the latter was responsible for the reduction. Similarly, phenolate (a phenoxide) has also
been used in the synthesis of AgNPs [53]. One of the advantages of this proposal is that all –OH
carrying compounds can generate alkoxide ions before transforming to ketones. This can be more
generalized, as all ‘reducing agents’ must possess at least one –OH group.
Further, most of the molecules employed as capping agents possess high molecular weights in
addition to at least one electro-negative element or group such as –NH2, –COOH, –SH, –OH, and –CO.
It is, therefore, hypothesized that groups such as –CO and –OH, being part of the precursors, must have
provided such stability. This is because the NPs were stable without the use of any external stabilizers.
The procyanidins dimers (and trimers) have great potential as antioxidant agents because of the
phenolic hydroxyls and ease of transferring an electron and H+ to enzymes and/or metals. Because of
the presence of stereogenic centres at C-2, C-3, and C-4, there are possible combinations for B-type
dimers (different possibilities of interflavane bonds between Cα/β-4 to C6/Cα/β-4 to C-8). In addition,
there are different conformers for each of the B-type dimers, however the extended (where B-rings are
facing each other) and compact (where B-rings are opposite each other) are the most dominant. In the
case of O-dioxy derivatives, the compact conformer has the minimum energy since the intra-hydrogen
bonding doesn’t play an important role in the stabilization of the extended conformer [54]. Not all the
procyanidin constituents were used in the formation of NPs. Therefore, the molecules in direct contact
with the metal NPs, most probably are the dioxy derivatives. The second and even third capping layers
can then be formed due to the inter-hydrogen bonding.
3.2. UV-Visibleible Analysis
The result of UV-Visible analysis of (A) LSTE-, (B) F1-, and (C) F2-AgNPs are shown in Figure 1.
The AgNPs exhibited surface plasmon resonance (SPR) bands between 424–432 nm, which confirmed
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the successful formation of the nanoparticles. A colour change was also observed within 10 min
from yellowish to brownish (inset in Figure 1) when 1 mM silver nitrate (AgNO3) solution (D) was
added, which indicated the successful synthesis of AgNPs. Hence, phytoconstituents in LSTE, F1,
and F2, acted as reducing agents and thereafter as capping agents during the synthesis of the AgNPs.
The similarity in the composition might have caused close SPR of the nanoparticles. No external
capping agents were used, implying that the respective constituents served as both the reducing and
capping agent. It is believed that polyphenols, abundantly available in plants, are responsible for the
reduction of metal salts in NP synthesis [55]. In this case, procyanidins are undoubtedly responsible
for the reduction and stabilization in both F1- and F2-AgNPs. The plasmonic resonance of AgNPs
spans the range of 320–500 nm according to previous studies [56,57]. In this study, the SPR of the
three AgNPs was observed to fall in the same range, which implies that the procyanidins with similar
functional groups are the major contributing reducing and capping agents, even in the extract.
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Figure 1. Absorption spectra of (A) Leucosidea sericea total extract-, (B) F1-, and (C) F2-mediated silver
nanoparticles. The cuvettes labelled A-C (inset) represent the colour of the respective AgNPs while the
clear solution (D) shows the colour of 1 mM AgNO3 solution used for the biosynthesis.
3.3. HRTEM Analysis
Figure 2A–F shows the HRTEM images, the corresponding particle size distributions, and SAED
patterns of LSTE-, F1-, and F2-AgNPs. The average particle sizes were found to be 7.8 ± 2.9, 2.9 ± 0.8,
and 3.3 ± 1.2 nm respectively. F1- and F2-AgNPs wer more monodispersed and spherical in
shape. Dendritic shapes, however, were observed for the LSTE-AgNPs (Figure 2A). This dendritic
architecture s been previously reported [53,54]. Different shapes of silver NPs have been ascribed to
a number of factors including the distance of formation to thermodynamic equilibrium and the fact
that shape control f r biological synthe is is still in its infancy [58]. Furthermore, spherical shapes
were predominant for F1- and F2-AgNPs. The green synthesis of MNPs often results in nanoparticles
of differ nt shapes. The presence of a mixture of shapes uch as irregular, triangular, hexagonal,
and spherical is becaus of phytochemicals of different functional gro ps serving as reducing as well
as stabilizing agents [59]. On t other han , pr vious studies have shown that polyphenols in their
pure forms often account for nanoparticles with spherical shapes, w ich were also observed in this
st dy with F1- a d F2-AgNPs [51,60]. Similar shapes and sizes have also been reported, in agreement
with our findings [49,61]. Figure 2C,F,I depict the selecte area electron diffraction (SAED) patt rns of
LSTE-, F1-, and F2-AgNPs resp ctively. The brightly circular patt rns i icate that the particles are
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polycrystalline and can be indexed to the (111), (200), (220), and (311) planes of a face-centred cubic
(FCC) structure of silver [51].
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Figure 2. High-Resolution transmi sion electron icr s i -,
F1-, and F2-mediated silver na oparticles are rep sented as (A,D,G) and the corresponding particle
size distr butions as (B,E,H) respectively. The corresponding selected area electron diffraction pa tern
o the respec ive HRTEM images are represented a (C,F,I).
3.4. XRD Analysis
Figure 3 displays the XRD markings of the AgNPs. The 2θ (degree) values of 38.2, 44.4, 64.6,
and 77.5 correlate orderly with the (111), (200), (220), and (311) planes of a face-centred cubic (FCC) silver
lattice [62], in agreement with the standard silver structure (JCPS no. 04-0783). The XRD decoration
also indicated that the biosynthesized silver nanoparticles are crystalline. Further supporting evidence
of crystallinity are given by the presence of bright spots observed in the SAED patterns in Figure 2.
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Figure 3. X-ray Diffraction patterns of the silver nanoparticles formed from Leucosidea sericea total
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3.5. DLS Measurement
LSTE-, F1-, and F2-AgNPs show hydrodynamic sizes of 87.64, 95.17, and 148.80 nm respectively
(Table 1). In most cases, smaller sizes are always recorded by TEM compared to the Zetasizer [63].
Although the size difference is often not more than two-fold, the literature records cases of wider
difference. Siddiqi and colleagues [64] reported an average hydrodynamic size of 437.1 nm for AgNPs
whereas the TEM measurement showed 9.40–11.23 nm. The vast difference in sizes obtained could be
due to the different sampling volume used during the TEM and DLS measurements.
Table 1. Particle size and zeta potential for AgNPs obtained from Dynamic Light Scattering.
Items Hydrodynamic Size (nm) Polydisperity Index Zeta Potential (mV)
LSTE-AgNPs 87.64 0.398 −25.7
F1-AgNPs 95.17 0.393 −29.4
F2-AgNPs 148.80 0.472 −28.8
The polydisperity index (PDI), otherwise called the heterogeneity index, is the degree of
non-uniformity of the size distribution of particles [65]. PDI is dimensionless and different size
algorithms work with values between 0.05–0.7. According to the standard, PDI values of 0.05 and
below are highly monodispersed. On the other hand, values greater than 0.7 shows broad particle size
distribution [65]. In this context, the PDI is approximately 0.5, tending towards the extreme of 0.7 and
further supporting the shape of F2-AgNPs. Therefore, LSTE- and F1-AgNPs possess more uniform
particles and are stable to a similar extent. F2-AgNPs with larger sizes and a mixture of shapes have the
tendency to aggregate faster owing to fewer capping agents. The zeta potential (ZP) is associated with
charges around nanoparticles. When ZP is less than −30 mV, it means particles are mostly surrounded
by negative charges. The magnitude of ZP determines the stability of the particles. Thus, the higher the
value, the better the stability. The ZP of AgNPs indicates good stability [66]. The bimodal distribution
of F2-AgNPs (Figure S1) is an indication that particles of different morphologies are present.
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3.6. In Vitro Stability Study
As with the size and morphology, the stability of nanoparticles is of great significance for their
application, especially in biological systems. Particles should retain their known properties even as
they interact with cells and other biomolecules. As displayed in Figure S2, the UV-Visible measurement
was termed 0 h (A1, B1, C1) upon the addition of various solutions to the respective AgNPs. Aqueous,
saline, protein, and buffer solutions interacted with F1-, F2-, and LSTE-AgNPs. The absorbance
indicates that all solutions interacted similarly with the NPs, except BSA. The chemical structure and
reaction of BSA differ from those of glycine and cysteine. It has been reported that BSA possesses about
50 lysines on its surface, rendering it to show a high affinity for negative surfaces [67]. Interestingly,
the AgNPs in this study are surrounded by negative ions as suggested by negative ZP values. Therefore,
this results in an enhanced interaction between the AgNPs and BSA. Although the interaction lowers
after 48 h in the case of F1 and LSTE, it was still high for F1 at the same time point. This may also be
due to a slightly higher ZP value of F1 compared to others. By 24 h, changes became more visible by
other solutions. The blue or redshifts were minimal for F1 (A2) and LSTE (C2) but more pronounced
for F2 (B2). This behaviour could be attributed to the homo- or heterogeneity of the NPs. PDI values of
0.393 and 0.398 were recorded for F1- and LSTE-AgNPs respectively, while 0.472 was observed for F2.
This implies that F1- and LSTE-AgNPs were relatively more uniform in shape than the F2-AgNPs [65].
This trend continued in the 48-hr measurement. At this time, even the F1 and LSTE-AgNPs displayed
slight variations. It could be observed that the extent of segregation of the absorbance peaks had
also increased in the F1-AgNPs such that the stability of the NPs is in the order of LSTE > F1 > F2.
This may be due to the abundance of phytochemicals involved in the formation and encapsulation of
LSTE-AgNPs. The temperature of 37 ◦C, the biological media, and physiological pH were selected to
mimic the human body conditions. If the particles interacted with the chosen molecules and retain their
characteristic features at such conditions, it can be inferred that further biological studies are necessary.
Thus, the evaluation confirms that they can interact with cells without losing their properties.
3.7. Dilution Study
Since certain biological applications may require different concentrations of AgNPs, dilution
studies are necessary to confirm the retention of properties before future utilization [40]. Figure 4
shows the UV-Visible results of (A) LSTE-, (B) F1-, and (C) F2-AgNPs. The absorption spectra obtained
for the different concentrations of the nanoparticles (80, 60, 40, 20, 10, and 5 µg/mL) suggest that the
SPR wavelengths are almost identical for all the solutions. This means that the dilution of nanoparticles
does not affect the properties of LSTE-, F1-, and F2-AgNPs [40]. Furthermore, the study of intensity
versus concentration affirmed a proportional relationship, as depicted in Figure 4D. The importance of
this dilution study is in the dosage to be used for certain applications. For the prepared nanoparticles
to be active at any given concentration, their physicochemical features need to be retained. One of the
quickest ways to confirm this is through their absorbance in UV-Visible spectroscopy, a powerful tool
in green synthesis. Thus, if there was no absorbance at the expected region, it may be inferred that the
particles have lost their properties and may not be useful at such concentration. This serves as a guide
for subsequent applications and consideration of another principle of green chemistry (atom economy).
3.8. In-Vitro Enzyme Inhibition
Table 2 depicts the enzyme inhibitory IC50 values of the three AgNPs alongside their corresponding
intact fractions. Alpha-glucosidase inhibitory IC50 values of 21.48 and 18.76 µg/mL were recorded for
LSTE- and F1-AgNPs, respectively. These activities imply that the AgNPs possess potent inhibitory
characteristics when compared to the standard drug, acarbose. However, when considering F2-AgNPs,
it showed a similar inhibition activity as that of its precursor (F2), perhaps because of the remains
of procyanidins on the surface of the nanoparticles as capping agents. On the other hand, LSTE-
and F1-AgNPs displayed moderate alpha-amylase inhibitory activity in comparison with acarbose
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even though LSTE still showed a very high inhibition when compared to its corresponding NPs.
Interestingly, F1-AgNPs displayed improved alpha-amylase inhibitory activity when compared to its
intact fraction, F1, displaying no inhibition. The percentage inhibition at various concentrations was
presented in Figure 5.J. Funct. Biomater. 2020, 11, x FOR PEER REVIEW 11 of 20 
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Table 2. The enzymatic inhibitory activity, expressed as IC50 of the Leucosidea sericea total extract (LSTE),
the intact fractions (F1 and F2), and those of their corresponding silver nanoparticles (LSTE-, F1- and
F2-AgNPs) using two assays (µg/mL).
Items Alpha-Amylase (IC50) (µg/mL) Alpha-Glucosidase (IC50) (µg/mL)
LSTE 3.50 ± 0.70 a 8.10 ± 0.60 a
LSTE-AgNPs 14.92 ± 1.0 b 21.48 ± 0.90 b
F1 NA 7.30 ± 0.50 a
F1-AgNPs 13.24 ± 0.60 b 18.76 ± 1.00 c
F2 18.9 ± 0.20 c 7.10 ± 0.40 a
F2-AgNPs 19.13 ± 0.80 c 8.75 ± 0.70 a
Acarbose 10.20 ± 0.40 d 61.00 ± 1.50 d
The results are expressed as mean ± SD of three different independent experiments (n = 3). Results not sharing a
common superscript alphabet (a–d) are significantly different (p < 0.01). Acarbose (standard), NA (not active at the
tested concentrations).
As stated earlier for alpha-glucosidase, F2-AgNPs also showed a similar IC50 value as its precursor
(F2) for alpha-amylase. This may be linked to the unique characteristics of these NPs including its
morphology. It further shows that the activity may be dependent on size, shape, and other factors such
as the type of phytochemical involved as the reductant and capping agent [46]. Previously, AgNPs have
displayed alpha-glucosidase inhibition [30]. Our results are also supported by previous antidiabetic
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studies of AgNPs [30,31,68]. In summary, the AgNPs in this study demonstrated interesting enzymatic
activity, although mostly lower than those of the corresponding precursors, the most important fact is
that they showed inhibitory activities.J. Funct. Biomater. 2020, 11, x FOR PEER REVIEW 12 of 20 
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Figure 5. Antidiabetic activities with regards to alpha-amylase (A) and alpha-glucosidase (B) inhibition
by Leucosidea sericea total extract (LSTE), procyanidin fractions (F1 and F2), and their respective silver
nanoparticles (LSTE-, F1-, and F2-AgNPs).
3.9. Antioxidant Activity
Antioxidants possess free radical scavenging abiliti s. Table 3 reports the scavenging ability of the
three AgNPs biosynthesized from LSTE, F1, and F2 and the respective intact fractions. The antioxidant
activities, as measured by the FRAP, ABTS, and FC assays, of the intact fractions were significantly
(p < 0.01) higher than those of their corresponding AgNPs. For instance, when considering the ABTS
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assay, all the fractions, roughly showed a doubling of antioxidant activity when compared to the hybrid
nanoparticles. This could be ascribed to a change in the functional groups during the nanoparticle
formation, rendering them unavailable to participate in the scavenging activity with a subsequent
reduction in the antioxidant activity. The antioxidant activity as the equivalence of the standard (Trolox,
vitamin C, and gallic acid) for ABTS, FRAP, and FC assays respectively, has been shown in Figure 6.
Table 3. The antioxidant activity of the L. sericea total extract (LSTE), the intact fractions (F1 and F2),
and those of their corresponding silver nanoparticles (LSTE-, F1-, and F2-AgNPs) using three assays
(ABTS, FRAP, and FC). The percentage phenolic content (FC) of the silver nanoparticles is also presented
in the last column of the table.
Items ABTS (mMTE/g) FRAP (mM AAE/g) FC (mM GAE/g) FC % (AgNPs)
LSTE 814.18 ± 1.80 a 1113.20 ± 6.70 a 602.60 ± 6.10 a 100
LSTE-AgNPs 499.65 ± 1.50 b 1438.50 ± 5.60 b 578.27 ± 7.70 b 57.8
F1 818.20 ± 7.70 a 1834.00 ± 4.70 c 889.60 ± 6.00 c 100
F1-AgNPs 319.18 ± 1.80 c 1361.60 ± 6.70 d 175.25 ± 2.60 d 17.5
F2 861.90 ± 5.30 d 1166.00 ± 2.10 e 685.70 ± 6.70 e 100
F2-AgNPs 583.22 ± 7.30 e 326.20 ± 2.20 f 357.80 ± 5.30 f 35.7
The results are expressed as mean ± SD of three different independent experiments (n = 3). Results not sharing a
common superscript alphabet (a–f) are significantly different (p < 0.01).
J. Funct. Biomater. 2020, 11, x FOR PEER REVIEW 13 of 20 
 
F2-AgNPs 19.13 ± 0.80 c 8.75 ± 0.70 a 
Acarbose 10.20 ± 0.40 d 61.00 ± 1.50 d 
The results are expressed as mean ± SD of three different independent experiments (n = 3). Results not 
sharing a common superscript alphabet (a,b,c,d,e) are significantly different (p < 0.01). Acarbose 
(stand rd), NA (not active at the tested concentrations). 
As stated earlier for alpha-glucosidase, F2-AgNPs also showed a similar IC50 value as its 
precursor (F2) for alpha-amylase. This may be linked to the unique c ara teristics of se NPs 
including its morphology. It further sh ws that the activity may be depen ent on size, sha e, and 
other facto s such as  type of phytochemical involved as the reductant and capping agent [46]. 
Previously, AgNPs have displayed alph -glucosidase inhibition [30]. Our results are lso supported 
by previous antidiabetic studies of AgNPs [30,31,68]. In summary, the AgNPs in this study 
demonstrated interesting enzymatic activity, although mostly lower than those of the corresponding 
precursors, the most important fact is that they show d inhibitory activities. 
3.9. Antioxidant Activity 
Antioxidants possess free radical scavenging abilities. Table 3 reports the scavenging ability of 
the three AgNPs biosynthesized from LSTE, F1, and F2 and the respective intact fractions. The 
antioxidant activities, as measured by the FRAP, ABTS, and FC assays, of the intact fractions were 
significantly (p < 0.01) higher than those of their corresponding AgNPs. For instance, when 
considering the ABTS assay, all the fractions, roughly showed a doubling of antioxidant activity when 
compared to the hybrid nanoparticles. This could be ascribed to a change in the functional groups 
during the nanoparticle formation, rendering them unavailable to participate in the scavenging 
activity with a subsequent reduction in the antioxidant activity. The antioxidant activity as the 
equivalence of the standard (Trolox, vitamin C, and gallic acid) for ABTS, FRAP, and FC assays 
respectively, has been shown in Figure 6. 
 
Figure 6. Antioxidant activity in terms of the ABTS (2,2′-azino-bis-3-ethylbenzotiazolin-6- sulfonic 
acid), FRAP (ferric reducing antioxidant power), and FC (Folin–Ciocalteu) scavenging activity by 
Leucosidea sericea total extract (LSTE), procyanidin fractions (F1 and F2), and their respective silver 
nanoparticles (LSTE-, F1-, and F2-AgNPs). The antioxidant activities were measured based on the 
equivalence of standard antioxidants Trolox, vitamin C (ascorbic acid), and gallic acid. 
Figure 6. Antioxidant activity in terms of the ABTS (2,2′-azino-bis-3-ethylbenzotiazolin-6-sulfonic acid),
FRAP (ferric reducing antioxidant power), and FC (Folin–Ciocalteu) scavenging activity by Leucosidea
sericea total extract (LSTE), procyanidin fractions (F1 and F2), and their respective silver nanoparticles
(LSTE-, F1-, and F2-AgNPs). The antioxidant activities were measured based on the equivalence of
standard antioxidants Trolox, vitamin C (ascorbic acid), and gallic acid.
When considering the FRAP assay outcomes, a similar trend was observed for the NPs and their
corresponding intact fractions, F1 and F2, but not for LSTE, which showed increased antioxidant
activity for its corresponding NP. On the other hand, when considering the FC assay outcomes,
similar antioxidant activities were observed for LSTE and its corresponding NP, but for F1 and F2,
their corresponding NPs showed a significantly lower antioxidant activity.
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The significantly higher antioxidant activity displayed by F2 vs. the F2-AgNPs could be due to
low stability, size, and heterogeneity of the latter. Evidently, LSTE-AgNPs displayed better activity
than F1- and F2-AgNPs and competes well with the intact fractions. This may be due to the abundance
of the phytochemicals surrounding the LSTE nanoparticles as capping agents [49]. Previously, it has
been suggested that the activity of nanomaterials may also be a function of the capping agents [46].
Our results were also in agreement with the activity reported by [49]. Reports have linked antioxidants
to many deadly diseases including diabetes, hence, materials with dual properties would be of great
benefit in reducing these menaces. A herbal formulation [69], the extracts of Ananas comosus [30],
and Chamaecostus cuspidatus [55] were previously employed in synthesizing NPs with encouraging
antidiabetic and antioxidant activities. Since certain antioxidants may also be implicated in adverse
health-effects, several studies have been done on the antioxidant properties of many biosynthesized
nanomaterials in the quest to finding more suitable alternatives [48,70,71].
3.10. The Antibacterial Assay of AgNPs
Silver nanoparticles have been in the lead in terms of antibacterial activities [72]. When various
plant parts were used for the synthesis, AgNPs have shown potent bactericidal effects on E. coli and
S. aureus [72]. In the current study, the antibacterial activities of the AgNPs were also studied using
wild species of both Gram-positive and Gram-negative bacteria. Serially diluted concentrations of the
AgNPs were used and the results showed that the MIC values were in the range of 15.63–125 µg/mL [67].
Bacterial growth inhibition varied between the AgNPs tested. Among the three AgNPs, the MIC
value of 62.50 µg/mL was most common (Table 4). This was particularly the case with F2-AgNPs
except for B. cereus where the MIC was at the highest concentration of 125 µg/mL. This was still
an improvement as none of the fractions showed any activity even above 1000 µg/mL. Similarly,
nanoparticles (NPs) with similar sizes and MICs have been reported [73]. Research has shown that
the activity of AgNPs is greatly associated with the concentration, shape, and size of the NPs [72,74],
and that AgNPs of small sizes at low concentrations are often effective antibacterial agents [75]. Various
researchers evaluated the activity of these NPs with different sizes and shapes against certain species
of bacteria [74,76,77] and found that 2.5–85 nm-sized AgNPs showed antibacterial activities, while the
most effective ones appeared to be between 2.5–20 nm. This implies that smaller silver nanoparticles
are highly effective antibacterial agents. In addition, other authors reported that the activities of AgNPs
may not only be due to small size but the overall morphology. While Shao et al. showed that the
enhanced antimicrobial activity was due to the small size and spherical shape of their particles, Sahu
and colleagues implicated small size and mono-dispersity over large and polydispersed ones [78,79].
From our TEM results, the average size was determined to be in the range of 2.9–7.8 nm. Consequently,
LSTE-AgNPs presented the lowest bactericidal activity. Although its MIC falls mostly at 62.50 µg/mL,
the percentage inhibitions were only moderate for P. aeruginosa and S. aureus respectively. The B. cereus
displayed a mild inhibition whereas S. marcescens were completely wiped out at the same concentration.
This was, however, not far-fetched as the heavy presence of phenolic content was still observed,
evidenced by the values presented in Table 3. It should be noted, however, that the intact fractions did
not show any activity even at high concentrations (2000 µg/mL). On the other hand, the bactericidal
effect of the AgNPs depends on the type of bacteria. In general, the Gram-negative bacterial species
responded better to the bactericidal effects of the AgNPs than the Gram-positive species. Previous
researchers have also shown this. It has been explained that the Gram-positive bacterial species possess
thicker cell walls which makes penetration more difficult. The thinner cell wall of the Gram-negative
species may have allowed easier interaction and possible disruption leading to more activity [80].
Overall, the bactericidal effects of our AgNPs appeared to be size-dependent. The smallest AgNPs
(2.9 nm) presented more bactericidal effects in four organisms. This includes; P. aeruginosa, B. cereus,
E. coli, with MIC of 31.25 µg/mL and even as low as 15.63 µg/mL for S. aureus. In a similar study,
the antibacterial activity of AgNPs on S. aureus at 16.12 µg/mL has been reported [81]. When the
particles are smaller, a larger surface area is available for contact with the bacteria, which could possibly
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lead to greater interaction with the bacteria. Therefore, F1-AgNPs had the largest contact with the
bacteria, and might possibly explain the enhanced antibacterial activities observed [82]. Furthermore,
previous studies have shown that the antimicrobial activity of a series of AgNPs increased as the size
decreased [83]. Our findings, therefore, agree with these studies.
Table 4. The minimum inhibitory concentration (MIC, µg/mL) values of the L. sericea total extract
(LSTE), the intact fractions (F1 and F2), and their corresponding silver nanoparticles (LSTE-, F1- and
F2-AgNPs) using six bacterial species.
Bacteria LSTE LSTE-AgNPs F1 F1-AgNPs F2 F2-AgNPs Control *
P. aeruginosa >2000 62.50 >2000 31.25 >2000 62.50 31.25
S. aureus >2000 62.50 >2000 15.63 >2000 62.50 15.63
B. cereus >2000 62.50 >2000 31.25 >2000 125.00 7.81
S. enterica >2000 31.25 >2000 31.25 >2000 62.50 7.81
E. coli >2000 62.50 >2000 31.25 >2000 62.50 15.63
S. marcescens >2000 125.00 >2000 62.50 >2000 62.50 3.90
* Ampicillin.
Finally, extensive research activities are on-going in the field of green nanotechnology. Several
authors have reported biosynthesis as a better procedure of forming nanoparticles while maintaining
the principles of green chemistry. This study and many others, as mentioned previously, showed the
potential of AgNPs as antibacterial agents and can form an important combination with antibiotics
against drug-resistant micro-organisms. On the other hand, the previous toxicity measurements
indicated marginal toxic effects of AgNPs in vitro [32,33]. In vivo studies are very limited but indicated
toxicity in rats. The toxicity of AgNPs largely depends on the surface charges and the stabilizing
(capping) agents which control the cells uptake of the NPs. A changing surface structure of AgNPs
may lead to safe AgNPs for human uses and also increase the bioactivity.
Further studies are required to investigate the effects of procyanidins as capping agents and other
natural compounds on the activity, cell uptake, and toxicity of the AgNPs. The future in vivo studies
are highly appreciated in this regard and considered to be essential and helpful to understand the
efficiency and safety of the prepared AgNPs utilizing edible, safe, and active compounds such as
procyanidins. In addition, investigation of the mechanism of action of AgNPs as a key factor is yet to
be established using different in vitro studies.
4. Conclusions
To our knowledge, this represents the first scientific research pertaining to the use of Leucosidea
sericea constituents for AgNPs fabrication and subsequent evaluation of their in vitro anti-diabetic,
antioxidant, and anti-bacterial activities. Capping agents play important roles in determining the
final characteristics of the metal NPs. The procyanidin dimers (type-B) were isolated and employed
to synthesise stable and bioactive AgNPs. The results are very encouraging and showed great
enhancement in the activities of the intact fractions. The natural products/nanoparticles combination is
a new important dimension in the area of drug discovery and the use of natural product compounds,
such as procyanidins, that have well-established pharmacological profiles will improve the future
usage of the metal NPs in the field of biomedical applications.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4983/11/3/66/s1,
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(A2) 24 h, (A3) 48 h, F2-AgNPs for (B1) 0 h, (B2) 24 h and (B3) 48 h and LSTE-AgNPs for (C1) 0 h, (C2) 24 h,
(C3) 48 h in different solutions.
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